N-Acetylcysteine Clinical Trials

6 actively recruiting trials across 4 locations

Also known as: N-AC, NAC, NAC; Acetylcysteine; N-acetyl-cysteine; N-acetyl-L-cysteine

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

University of Cincinnati1
University of California, Irvine1
State University of New York - Upstate Medical University1
National University of Malaysia1
Michio Hirano, MD1

Indications

Alcoholic Hepatitis1
Mild Depression1
Mitochondrial Disease1
Liver Disease1
MPN1

Other2 trials

Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD Patients

N/A

Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)

N/A

Irvine, California1 trial

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

University of California, Irvine

Phase 1/2

Los Angeles, California1 trial

Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine

Cedars-Sinai Medical Center

Phase 2

New York, New York1 trial

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Columbia University Irving Medical Center

Phase 1

Cincinnati, Ohio1 trial

Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth

University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.